Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1756 AL 1770

Validation of the Thai SCOPA-sleep scale for assessment of sleep and sleepiness in patients with Parkinson's disease

Setthawatcharawanich S, Limapichat K, Sathirapanya P, Phabphal K.

J Med Assoc Thai. 2011 Feb;94(2):179-84.

Pilot dietary study with normoproteic protein-redistributed plant-food diet and motor performance in patients with Parkinson's disease

Baroni L, Bonetto C, Tessan F, Goldin D, Cenci L, Magnanini P, Zuliani G.

Nutr Neurosci. 2011 Jan;14(1):1-9. doi: 10.1179/174313211X12966635733231.

Evaluating intra-genetic variants of DJ-1 among Parkinson's disease patients of eastern India

Sanyal J, Sarkar B, Banerjee TK, Mukherjee SC, Ray BC, Raghavendra Rao V.

Neurol Res. 2011 May;33(4):349-53. doi: 10.1179/016164110X12767786356679.

The emergence of designed multiple ligands for neurodegenerative disorders

Geldenhuys WJ, Youdim MB, Carroll RT, Van der Schyf CJ.

Prog Neurobiol. 2011 Sep 1;94(4):347-59. doi: 10.1016/j.pneurobio.2011.04.010. Epub 2011 Apr 22.

Rotigotine-induced nail dyschromia in a patient with Parkinson disease

Teive HA, Munhoz RP.

Neurology. 2011 May 3;76(18):1605. doi: 10.1212/WNL.0b013e3182190f62.

RNAi: a potential new class of therapeutic for human genetic disease

Seyhan AA.

Hum Genet. 2011 Nov;130(5):583-605. doi: 10.1007/s00439-011-0995-8. Epub 2011 May 3.

ATXN-2 CAG repeat expansions are interrupted in ALS patients

Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D'Alfonso S.

Hum Genet. 2011 Oct;130(4):575-80. doi: 10.1007/s00439-011-1000-2. Epub 2011 May 3.

[Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder]

De Schutter P, Bouckaert F, Peuskens J.

Tijdschr Psychiatr. 2011;53(5):299-303.

A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease

Shill HA, Obradov S, Katsnelson Y, Pizinger R.

Mov Disord. 2011 Jul;26(8):1477-80. doi: 10.1002/mds.23591. Epub 2011 Apr 29.

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease

Wong KK, Alty JE, Goy AG, Raghav S, Reutens DC, Kempster PA.

Mov Disord. 2011 Jul;26(8):1552-5. doi: 10.1002/mds.23687. Epub 2011 Apr 29.

Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

Yue Z, Lachenmayer ML.

Mov Disord. 2011 Jul;26(8):1386-97. doi: 10.1002/mds.23737. Epub 2011 Apr 29.

Atrial Fibrillation in the Wolff-Parkinson-White Syndrome

Centurion OA.

J Atr Fibrillation. 2011 May 4;4(1):287. doi: 10.4022/jafib.287. eCollection 2011 May-Jun.

Computed Tomography Imaging in Atrial Fibrillation Ablation

Sharma K, Brinker JA, Henrikson CA.

J Atr Fibrillation. 2011 May 4;4(1):319. doi: 10.4022/jafib.319. eCollection 2011 May-Jun.

Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010

López A, Tarragó T, Giralt E.

Expert Opin Ther Pat. 2011 Jul;21(7):1023-44. doi: 10.1517/13543776.2011.577416. Epub 2011 May 3.

Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding

Cilia R, van Eimeren T.

Brain Struct Funct. 2011 Nov;216(4):289-99. doi: 10.1007/s00429-011-0314-0. Epub 2011 May 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias